American Medical Research, Inc.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Schizophrenia1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed3 trials

Lead sponsor

• Jazz Pharmaceuticals1 trial
• Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial

Closed trials

• Completed

  A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.

  NCT05279313· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Completed

  A Study of JZP150 in Adults With Posttraumatic Stress Disorder

  NCT05178316· Phase 2· Jazz Pharmaceuticals· Source

• Completed

  A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

  NCT05145413· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source